Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Precision Drilling
PDS
5
Lantheus
LNTH
US OptionsDetailed Quotes
VRNA250516P55000
- 0.26
- -0.09-25.71%
15min DelayClose May 9 16:00 ET
0.36High0.26Low
0.36Open0.35Pre Close35 Volume5.69K Open Interest55.00Strike Price1.23KTurnover83.32%IV13.55%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type-0.0818Delta0.0226Gamma243.54Leverage Ratio-0.0823Theta-0.0008Rho-19.92Eff Leverage0.0121Vega
Verona Pharma Newsroom
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading
What Makes Verona Pharma Plc (VRNA) a Good Investment?
News Flash: Analysts Just Made A Meaningful Upgrade To Their Verona Pharma Plc (NASDAQ:VRNA) Forecasts
Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025
Express News | Form 144 | Verona Pharma(VRNA.US) Officer Proposes to Sell 3.61 Million in Common Stocks
Express News | Form 144 | Verona Pharma(VRNA.US) Director Proposes to Sell 3.61 Million in Common Stocks
Verona Pharma Price Target Raised to $107 From $93 at Wells Fargo
Verona Pharma Insider Sold Shares Worth $811,433, According to a Recent SEC Filing
A Quick Look at Today's Ratings for Verona Pharma(VRNA.US), With a Forecast Between $85 to $107
Why Verona Pharma Plc (VRNA) Soared on Tuesday
Verona Pharma Price Target Raised to $107.00/Share From $93.00 by Wells Fargo
Analysts' Opinions Are Mixed on These Healthcare Stocks: The Ensign Group (ENSG), Verona Pharma (VRNA) and Atricure (ATRC)
Verona Pharma Is Maintained at Buy by HC Wainwright & Co.
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH), Incyte (INCY) and Verona Pharma (VRNA)
Verona Pharma Analyst Ratings
Analysts Are Betting On Verona Pharma Plc (NASDAQ:VRNA) With A Big Upgrade This Week
Express News | Verona Pharma PLC : Canaccord Genuity Raises Target Price to $106 From $72
Earnings Call Summary | Verona Pharma(VRNA.US) Q1 2025 Earnings Conference
Verona Pharma Sees Ohtuvayre Sales Doubling in Q1 2025, Projects Expanded Sales Team by Q3
Truist Securities Adjusts Verona Pharma Price Target to $100 From $76, Maintains Buy Rating
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
